Activation of extracellular transglutaminase 2 by mechanical force in the arterial wall

Journal of Vascular Research

Volumn 50, Issue 5, 2013, Pages 383-395

  Huelsz Prince, Guizela ^a   Belkin, Alexey M ^b   Vanbavel, Ed ^a   Bakker, Erik N T P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Mechanical force; Transglutaminase; Vascular remodeling

Indexed keywords

CALCIUM; FIBRONECTIN; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; INTEGRIN; NITRIC OXIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TALIN; VINCULIN;

ARTERIAL STIFFNESS; ARTERY WALL; CELL INTERACTION; CONFORMATIONAL TRANSITION; DISULFIDE BOND; ENZYME ACTIVATION; ENZYME CONFORMATION; ENZYME LOCALIZATION; ENZYME STRUCTURE; FORCE; HYPERTENSION; NONHUMAN; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR REMODELING; VASOCONSTRICTION;

EID: 84886795952     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000354222     Document Type: Review

References (69)

1. VanBavel E, Bakker ENTP, Pistea A, Sorop O, Spaan JAE: Mechanics of microvascular remodeling. Clin Hemorheol Microcirc 2006; 34: 35-41.
2. Mulvany MJ: Vascular remodelling of resistance vessels: can we define this? Cardiovasc Res 1999; 41: 9-13.
3. Van den Akker J, Schoorl MJC, Bakker ENTP, Vanbavel E: Small artery remodeling: current concepts and questions. J Vasc Res 2010; 47: 183-202.
4. Bakker ENTP, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, et al: Small artery remodeling depends on tissue-type transglutaminase. Circ Res 2005; 96: 119-126.
5. Van den Akker J, VanBavel E, Van Geel R, Matlung HL, Guvenc Tuna B, Janssen GMC, et al: The redox state of transglutaminase 2 controls arterial remodeling. PloS One 2011; 6:e23067.
6. Pistea A, Bakker ENTP, Spaan JAE, Hardeman MR, Van Rooijen N, VanBavel E: Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases. J Vasc Res 2008; 45: 10-18.
7. Bakker ENTP, Pistea A, Spaan JAE, Rolf T, De Vries CJ, Van Rooijen N, et al: Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ Res 2006; 99: 86-92.
8. Kiraly R, Demeny M, Fesus L: Protein transamidation by transglutaminase 2 in cells: a disputed Ca 2+-dependent action of a multifunctional protein. FASEB J 2011; 278: 4717-4739.
9. Lorand L, Graham RM: Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4: 140-156.
10. Zemskov EA, Janiak A, Hang J, Waghray A, Belkin AM: The role of tissue transglutaminase in cell-matrix interactions. Front Biosci 2006; 11: 1057-1076.
11. Bakker ENTP, Pistea A, VanBavel E: Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res 2008; 45: 271-278.
12. Gundemir S, Colak G, Tucholski J, Johnson GVW: Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta 2012; 1823: 406-419.
13. Casadio R, Polverini E, Mariani P, Spinozzi F, Carsughi F, Fontana A, et al: The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem 1999; 262: 672-679.
14. Liu S, Cerione RA, Clardy J: Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 2002; 99: 2743-2747.
15. Han BG, Cho JW, Cho YD, Jeong KC, Kim SY, Lee Bl: Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate. Int J Biol Macromol 2010; 47: 190-195.
16. Pinkas DM, Strop P, Brunger AT, Khosla C: Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 2007; 5:e327.
17. Engholm M, Eftekhari A, Chwatko G, Bald E, Mulvany MJ: Effect of cystamine on blood pressure and vascular characteristics in spontaneously hypertensive rats. J Vasc Res 2011; 48: 476-484.
18. Santhanam L, Tuday EC, Webb AK, Dowzicky P, Kim JH, Oh YJ, et al: Decreased Snitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res 2010; 107: 117-125.
19. Mariani P, Carsughi F, Spinozzi F, Romanzetti S, Meier G, Casadio R, et al: Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data. Biophys J 2000; 78: 3240-3251.
20. Ahvazi B, Kim HC, Kee S-H, Nemes Z, Steinert PM: Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation. EMBO J 2002; 21: 2055-2067.
21. Fox BA, Yee VC, Pedersen LC, Le I, Bishop PD, Stenkamp RE, et al: Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by X-ray crystallography. J Biol Chem 1999; 274: 4917-4923.
22. Begg GE, Carrington L, Stokes PH, Matthews JM, Wouters MA, Husain A, et al: Mechanism of allosteric regulation of transglutaminase 2 by GTP. Proc Natl Acad Sci USA 2006; 103: 19683-19688.
23. Watts SW, Priestley JRC, Thompson JM: Serotonylation of vascular proteins important to contraction. PLoS One 2009; 4:e5682.
24. Johnson KB, Thompson JM, Watts SW: Modification of proteins by norepinephrine is important for vascular contraction. Front Physiol 2010; 1: 131.
25. Siegel M, Strnad P, Watts RE, Choi K, Jabri B, Omary MB, et al: Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PloS One 2008; 3:e1861.
26. Lai TS, Hausladen A, Slaughter TF, Eu JP, Stamler JS, Greenberg CS: Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 2001; 40: 4904-4910.
27. Jandu SK, Webb AK, Pak A, Sevinc B, Nyhan D, Belkin AM, et al: Nitric oxide regulates tissue transglutaminase localization and function in the vasculature. Amino Acids 2013; 44: 261-269.
28. Santhanam L, Berkowitz DE, Belkin AM: Nitric oxide regulates non-classical secretion of tissue transglutaminase. Commun Integr Biol 2011; 4: 584-586.
29. Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C, Sollid LM: Redox regulation of transglutaminase 30 activity. J Biol Chem 2010; 285: 25402-25409.
30. Chung SI, Folk JE: Mechanism of the inactivation of guinea pig liver transglutaminase by tetrathionate. J Biol Chem 1970; 245: 681-689.
31. Jin X, Stamnaes J, Klock C, DiRaimondo TR, Sollid LM, Khosla C: Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem 2011; 286: 37866-37873.
32. Caccamo D, Curro M, Ferlazzo N, Condello S, Ientile R: Monitoring of transglutaminase 2 under different oxidative stress conditions. Amino Acids 2012; 42: 1037-1043.
33. Belkin AM: Extracellular TG2: emerging functions and regulation. FEBS J 2011; 278: 4704-4716.
34. Akimov SS, Krylov D, Fleischman LF, Belkin AM: Tissue transglutaminase is an integrinbinding adhesion coreceptor for fibronectin. J Cell Biol 2000; 148: 825-838.
35. Janiak A, Zemskov EA, Belkin AM: Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 2006; 17: 1606-1619.
36. Katsumi A, Orr AW, Tzima E, Schwartz MA: Integrins in mechanotransduction. J Biol Chem 2004; 279: 12001-12004.
37. Parsons JT, Horwitz AR, Schwartz MA: Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 2010; 11: 633-643.
38. Eyckmans J, Boudou T, Yu X, Chen CS: A hitchhiker's guide to mechanobiology. Dev Cell 2011; 21: 35-47.
39. Hoffman BD, Grashoff C, Schwartz MA: Dynamic molecular processes mediate cellular mechanotransduction. Nature 2011; 475: 316-323.
40. Roca-Cusachs P, Iskratsch T, Sheetz MP: Finding the weakest link: exploring integrinmediated mechanical molecular pathways. J Cell Sci 2012; 125: 3025-3038.
41. Chen CS: Mechanotransduction-a field pulling together? J Cell Sci 2008; 121: 3285-3292.
42. Schwartz MA: Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol 2010; 2:a005066.
43. Ingber DE: Cellular mechanotransduction: putting all the pieces together again. FASEB J 2006; 20: 811-827.
44. Orr AW, Helmke BP, Blackman BR, Schwartz MA: Mechanisms of mechanotransduction. Dev Cell 2006; 10: 11-20.
45. Singh P, Carraher C, Schwarzbauer JE: Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 2010; 26: 397-419.
46. Gee EPS, Ingber DE, Stultz CM: Fibronectin unfolding revisited: modeling cell tractionmediated unfolding of the tenth type-III repeat. PloS One 2008; 3:e2373.
47. Klotzsch E, Smith ML, Kubow KE, Muntwyler S, Little WC, Beyeler F, et al: Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites. Proc Natl Acad Sci USA 2009; 106: 18267-18272.
48. Brown AEX, Discher DE: Conformational changes and signaling in cell and matrix physics. Curr Biol 2009; 19:R781-R789.
49. Johnson CP, Tang H-Y, Carag C, Speicher DW, Discher DE: Forced unfolding of proteins within cells. Science 2007; 317: 663-666.
50. Brakebusch C, Fassler R: The integrin-actin connection, an eternal love affair. EMBO J 2003; 22: 2324-2333.
51. Geiger B, Bershadsky A, Pankov R, Yamada KM, Correspondence BG: Transmembrane extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2001; 2: 793-805.
52. Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C: Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol 2007; 179: 1043-1057.
53. Carisey A, Tsang R, Greiner AM, Nijenhuis N, Heath N, Nazgiewicz A, et al: Vinculin regulates the recruitment and release of core focal adhesion proteins in a force-dependent manner. Curr Biol 2013; 23: 271-281.
54. Peng X, Nelson ES, Maiers JL, DeMali KA: New insights into vinculin function and regulation. Int Rev Cell Mol Biol 2011; 287: 191-231.
55. Rio A, Perez-Jimenez R, Liu R, Roca-Cusachs P, Fernandez JM, Sheetz MP: Stretching single talin rod molecules activates vinculin binding. Science 2009; 323: 638-641.
56. Vogel V: How force might activate talin's vinculin binding sites: SMD reveals a structural mechanism. PLoS Comput Biol 2008; 4:e24.
57. Campbell ID, Humphries MJ: Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol 2011; 3:a004994.
58. Askari JA, Buckley PA, Mould AP, Humphries MJ: Linking integrin conformation to function. J Cell Sci 2009; 122: 165-170.
59. Friedland JC, Lee MH, Boettiger D: Mechanically activated integrin switch controls alpha5beta1 function. Science 2009; 323: 642-644.
60. Kong F, Garcia AJ, Mould AP, Humphries MJ, Zhu C: Demonstration of catch bonds between an integrin and its ligand. J Cell Biol 2009; 185: 1275-1284.
61. Kong F, Li Z, Parks WM, Dumbauld DW, Garcia AJ, Mould AP, et al: Cyclic mechanical reinforcement of integrin-ligand interactions. Mol Cell 2013; 49: 1060-1068.
62. Puklin-Faucher E, Gao M, Schulten K, Vogel V: How the headpiece hinge angle is opened: new insights into the dynamics of integrin activation. J Cell Biol 2006; 175: 349-360.
63. Zhong C, Chrzanowska-Wodnicka M, Brown J, Shaub A, Belkin AM, Burridge K: Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol 1998; 141: 539-551.
64. Cao L, Zeller MK, Fiore VF, Strane P, Bermudez H, Barker TH: Phage-based molecular probes that discriminate force-induced structural states of fibronectin in vivo. Proc Natl Acad Sci USA 2012; 109: 7251-7256.
65. Fan SW, George RA, Haworth NL, Feng LL, Liu JY, Wouters MA: Conformational changes in redox pairs of protein structures. Protein Sci 2009; 18: 1745-1765.
66. Wiita AP, Rama S, Ainavarapu K, Huang HH, Fernandez JM: Force-dependent chemical kinetics of disulfide bond reduction observed with single-molecule techniques. Proc Natl Acad Sci USA 2006; 113: 7222-7227.
67. Sun Q-H, Liu C-Y, Wang R, Paddock C, Newman PJ: Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes. Blood 2002; 100: 2094-2101.
68. Langenbach KJ, Sottile J: Identification of protein-disulfide isomerase activity in fibronectin. J Biol Chem 1999; 274: 7032-7038.
69. Pavlyukov MS, Antipova NV, Balashova MV, Shakhparonov MI: Detection of transglutaminase 2 conformational changes in living cell. Biochem Biophys Res Commun 2012; 421: 773-779.